Shefali Shah, MD | |
306 N 7th St, Columbia, PA 17512-2137 | |
(717) 684-9106 | |
Not Available |
Full Name | Shefali Shah |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 33 Years |
Location | 306 N 7th St, Columbia, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659344273 | NPI | - | NPPES |
080175948 | Other | PA | RR MEDICARE |
3968032 | Other | PA | AETNA-HMO |
20040361 | Other | PA | MERCY |
729782000 | Other | PA | INDEPENDENCE BLUE CROSS |
P006097 | Other | PA | GATEWAY |
PCP-000000128588 | Other | PA | UNISON |
5015114 | Other | PA | AETNA-NON HMO |
001703480 | Medicaid | PA | |
9376951 | Other | PA | CIGNA |
000977113 | Other | PA | HIGHMARK |
50055886 | Other | PA | CAPITAL BLUE CROSS & KEYSTONE HEALTH PLAN CENTRAL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD06572L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lancaster General Hospital | Lancaster, PA | Hospital |
York Hospital | York, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lancaster General Health - Columbia Center | 1254241359 | 22 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that data from its Phase 3 (FAME) clinical trials for Iluvien will be presented this month at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago.
Rates of premature births have increased in recent years, affecting more than 12% of all births and making strategies for managing the associated perinatal complications an important public goal. Preterm infants are particularly at risk for bronchopulmonary dysplasia (BPD), a chronic lung disease. BPD has multiple causes, and uncovering critical interactions within the immune system can lead to new approaches for treatment.
A study co-authored by Boston University School of Public Health researchers and published in the American Journal of Industrial Medicine finds that an injury serious enough to lead to at least a week off of work almost triples the combined risk of suicide and overdose death among women, and increases the risk by 50 percent among men.
Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at 'intermediate risk' who can safely avoid immediate treatment and benefit from 'active surveillance' instead.
› Verified 2 days ago
Entity Name | Lancaster General Health - Columbia Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700972338 PECOS PAC ID: 1254241359 Enrollment ID: O20040128000813 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that data from its Phase 3 (FAME) clinical trials for Iluvien will be presented this month at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago.
Rates of premature births have increased in recent years, affecting more than 12% of all births and making strategies for managing the associated perinatal complications an important public goal. Preterm infants are particularly at risk for bronchopulmonary dysplasia (BPD), a chronic lung disease. BPD has multiple causes, and uncovering critical interactions within the immune system can lead to new approaches for treatment.
A study co-authored by Boston University School of Public Health researchers and published in the American Journal of Industrial Medicine finds that an injury serious enough to lead to at least a week off of work almost triples the combined risk of suicide and overdose death among women, and increases the risk by 50 percent among men.
Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at 'intermediate risk' who can safely avoid immediate treatment and benefit from 'active surveillance' instead.
› Verified 2 days ago
Entity Name | Lancaster General Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720430812 PECOS PAC ID: 1254240039 Enrollment ID: O20040414000606 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that data from its Phase 3 (FAME) clinical trials for Iluvien will be presented this month at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago.
Rates of premature births have increased in recent years, affecting more than 12% of all births and making strategies for managing the associated perinatal complications an important public goal. Preterm infants are particularly at risk for bronchopulmonary dysplasia (BPD), a chronic lung disease. BPD has multiple causes, and uncovering critical interactions within the immune system can lead to new approaches for treatment.
A study co-authored by Boston University School of Public Health researchers and published in the American Journal of Industrial Medicine finds that an injury serious enough to lead to at least a week off of work almost triples the combined risk of suicide and overdose death among women, and increases the risk by 50 percent among men.
Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at 'intermediate risk' who can safely avoid immediate treatment and benefit from 'active surveillance' instead.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Shefali Shah, MD 306 N 7th St, Columbia, PA 17512-2137 Ph: (717) 684-9106 | Shefali Shah, MD 306 N 7th St, Columbia, PA 17512-2137 Ph: (717) 684-9106 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that data from its Phase 3 (FAME) clinical trials for Iluvien will be presented this month at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago.
Rates of premature births have increased in recent years, affecting more than 12% of all births and making strategies for managing the associated perinatal complications an important public goal. Preterm infants are particularly at risk for bronchopulmonary dysplasia (BPD), a chronic lung disease. BPD has multiple causes, and uncovering critical interactions within the immune system can lead to new approaches for treatment.
A study co-authored by Boston University School of Public Health researchers and published in the American Journal of Industrial Medicine finds that an injury serious enough to lead to at least a week off of work almost triples the combined risk of suicide and overdose death among women, and increases the risk by 50 percent among men.
Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at 'intermediate risk' who can safely avoid immediate treatment and benefit from 'active surveillance' instead.
› Verified 2 days ago
Diane K Donnelly, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3985 Columbia Ave Ste 8, Columbia, PA 17512 Phone: 717-285-3144 Fax: 717-285-3529 | |
Kelsey Czekai, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 369 Locust Street, First Floor, Columbia, PA 17512 Phone: 717-342-2577 Fax: 717-449-5082 | |
Thomas C Coyne, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 N 7th St, Columbia, PA 17512 Phone: 717-684-9106 Fax: 717-684-1666 | |
Adrienne K Kuhlengel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 N 7th St, Columbia, PA 17512 Phone: 717-684-9106 Fax: 717-684-1666 | |
Dr. Adrian Farris Hazbun, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3985 Columbia Ave Ste 8, Columbia, PA 17512 Phone: 717-285-3144 Fax: 717-295-9098 | |
Dr. Eugene John Romano, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1786c Columbia Ave, Columbia, PA 17512 Phone: 717-684-3663 Fax: 717-684-9030 | |
Brian Young, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 N 7th St, Columbia, PA 17512 Phone: 717-684-9106 |